Dong-a St Co., Ltd.
Clinical trials sponsored by Dong-a St Co., Ltd., explained in plain language.
-
New drug DA-3501 takes on tough cancers: early trial begins
Disease control Recruiting nowThis early-stage trial tests an experimental drug called DA-3501 in people with advanced stomach, gastro-esophageal junction, or pancreatic cancer that has a specific protein (CLDN18.2). The drug is given intravenously every three weeks. The main goals are to find a safe dose and…
Phase: PHASE1 • Sponsor: Dong-A ST Co., Ltd. • Aim: Disease control
Last updated Jun 24, 2026 04:07 UTC
-
Healthy volunteers needed to compare two drug versions
Knowledge-focused Recruiting nowThis early-stage study tests the safety and how the body processes two versions of an experimental drug (DA-5223 and DA-5223-R) in 12 healthy adults aged 19 to 55. Participants receive a single dose of each version in random order, and researchers measure drug levels in the blood…
Phase: PHASE1 • Sponsor: Dong-A ST Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 22, 2026 12:06 UTC